Clinical Trials Directory

Trials / Completed

CompletedNCT01357369

Study of Drug Concentration of Ondansetron and Cefazolin in Mothers and Neonates

Pharmacokinetics and Placental Transfer of Ondansetron and Cefazolin: A Preliminary Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Stanford University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study proposes to look at the pharmacokinetics of two drugs (Cefazolin and ondansetron) given routinely to pregnant women who are planning to deliver via cesarean section. The investigators will evaluate the metabolism of both drugs by the pregnant woman, the placental transfer over time, and the subsequent metabolism of the transferred drug in the neonate.

Detailed description

There is very little data on drug metabolism during pregnancy, and how it may differ from the non-pregnant woman. There is even less data on placental transfer of drug to the neonate when medications are given prior to delivery. This study proposes to look at the pharmacokinetics of two drugs (Cefazolin and ondansetron) given routinely to pregnant women who are planning to deliver via cesarean section. The investigators will evaluate the metabolism of both drugs by the pregnant woman, the placental transfer over time, and the subsequent metabolism of the transferred drug in the neonate. The investigators hope to learn 1) the pk profile of both drugs in pregnancy, and how it differs from the non-pregnant woman, 2) the placental transfer of both drugs, and 3) the profile of neonatal metabolism of the drug that crosses the placental barrier.

Conditions

Interventions

TypeNameDescription
PROCEDUREPhlebotomyBlood samples will be drawn from the mother, umbilical vein and artery post delivery, and neonate with other clinical labs.

Timeline

Start date
2011-01-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-05-20
Last updated
2016-04-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01357369. Inclusion in this directory is not an endorsement.